Synartro

📍 Stockholm, Sweden🗓 Founded 2011👥 7 employees💰 Last funded Jun 2020
Pharmaceutical Manufacturing🌐 synartro.com
Website LinkedIn
Synartro is a Swedish pharmaceutical company developing local injection treatments aiming to provide superior and sustained efficacy without systemic side-effects. This is achieved by combining our patented delivery technology with existing proven drugs. Our pre-clinical lead program focuses on a novel therapy using our compound SYN321 for the treatment of osteoarthritis (OA). Currently this disease leaves up to 50% of patients without adequate pain relief.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Synartro?
Synartro has 2 investors on record on gritt.io and 2 late-stage investors.
When did Synartro last raise funding?
The most recent investment in Synartro recorded on gritt.io was in June 2020.
When was Synartro founded?
Synartro was founded in 2011.
What industry is Synartro in?
Synartro operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Synartro based?
Synartro is headquartered in Stockholm, Sweden.